Intra Cellular Therapies | Bruttoavancen På Salg



Gross Profit On Sales Lave om Dato
Acadia Pharmaceuticals USD 237.8M 72.86M 2024-12
ALKERMES USD 146.5M 168.54M 2024-12
Biogen USD 1.87B 44.1M 2024-12
Bristol-Myers Squibb USD 9.13B 94M 2024-12
Cytokinetics -160545000 81.19M 2024-09
Gilead Sciences USD 5.99B 17M 2024-12
Halozyme Therapeutics USD 255.95M 15.3M 2024-12
Intra Cellular Therapies USD 178.82M 18.75M 2024-12
J&J USD 15.41B 102M 2024-12
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
Novartis USD 10.24B 313M 2024-12
Prothena -59001000 66.45M 2024-09
RedHill Biopharma USD 584K 0 2024-06
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
United Therapeutics USD 660M 5.8M 2024-12



Intra Cellular Therapies Bruttoavancen På Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.